FindTrial
Sign In

Medications for children and adolescents with metabolic syndrome

Medications for children and adolescents with metabolic syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020528
Enrollment
Unknown
Registered
2019-01-06
Start date
2019-01-10
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

Group 1:single lifestyle intervention
Group 2:Metformin intervention
Group 3:L-carnitine intervention
Group 4:Metformin and L-carnitine intervention

Sponsors

Hu'nan Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Aged 6 to 18 years; 2. Diagnosed with Metabolic syndrome.

Exclusion criteria

Exclusion criteria: 1. Pancreatitis, peptic ulcer, dyspepsia; 2. hyperthyroidism, severe systemic diseases, severe hepatic dysfunction, severe renal impairment or malignant tumor; 3. Gastrointestinal diseases such as pancreatitis, peptic ulcer, dyspepsia etc.

Design outcomes

Primary

MeasureTime frame
Weight;Height;Waist circumference;Hip circumference;—

Countries

China

Contacts

Public ContactZheng Xi

Hu'nan Children's Hospital

rochesterzheng@sina.com+86 13469041416

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026